Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018)
Sutro Biopharma's (STRO) quarterly Other Non Operating Income came in at $1.1 million in Q4 2018, up 794.17% year-on-year from $120000.0 in Q4 2017, and up 1677.94% quarter-over-quarter from -$68000.0 in Q3 2018.
Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018) Analysis & Trends
Sutro Biopharma has disclosed Other Non Operating Income across 2 years of filings, most recently posting $1.1 million for Q4 2018.
- Other Non Operating Income for Q4 2018 came in at $1.1 million, up 794.17% year-over-year; the trailing twelve-month figure through Dec 2018 was $945000.0 (changed N/A YoY), and the FY2018 annual result was $1.9 million, up 2584.42% from the prior year.
- Other Non Operating Income came in at $1.1 million for Q4 2018 at Sutro Biopharma, up from -$68000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q4 2018 to a low of -$180000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | -68,000.00 |
| Dec 31, 2017 | 120,000.00 |
| Sep 30, 2017 | -180,000.00 |